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Although HIV continues to have a high prevalence among adults in sub-Saharan Africa (SSA), 
the burden of noncommunicable diseases (NCD) such as diabetes and hypertension is 
increasing rapidly. There is an urgent need to expand the capacity of healthcare systems in SSA 
to provide NCD services and scale up existing chronic care management pathways. A scoping 
review mapped extant policy and evidence based literature on the feasibility of integrating 
NCD care with HIV in the region. 
 
Methods 
A scoping review methodology was utilised to conduct a systematic search of peer-reviewed 
and grey literature published in English language and with no date limitation. A systematic 
search was conducted on PubMed, Embase, CINAHL, and the Cochrane library. The initial 
search identified 231 records considered for inclusion in this review. Twelve duplicate records 
were removed. The remaining 219 records were screened by title and abstract of which 165 
records were excluded and 54 records were selected for full-text review. A further 16 records 
were excluded due to a lack of relevance or the unavailability of the full text article. Finally, 
38 were charted and analysed thematically. 
 
Results 
Thirty-eight studies were included. These comprised a range of different models to integrate 
NCD and HIV care in the region, reflecting differences in health system environments, and 
disease epidemiology. The studies provide a variety of evidence that integration of HIV and 
NCD care can be feasible and can improve clinical effectiveness and identify barriers and 
facilitators to integration and task shifting. The review confirms that integrated HIV and NCD 
care services is by-and-large feasible, being both clinically effective and cost-effective. 
 
Conclusion  
The review may inform the understanding of how best to develop an integrated model of care 
service by reducing barriers to uptake, linkage and retention in HIV, diabetes and hypertension 
treatment in SSA countries. 
 






There is an increasing noncommunicable disease (NCD) burden globally, with an estimated 1 
billion people living with hypertension and about 9.4 million NCD-related deaths annually.[1] 
NCDs are important contributors to the burden of disease in countries at all stages of economic 
development, posing a high priority threat to public health worldwide.[2, 3] Over three-quarters 
of global NCD deaths (28 million) and the majority of premature deaths (82%) occur in low- 
and middle-income countries (LMICs).[4] Among global NCDs, type 2 diabetes mellitus (DM) 
is especially common.[5, 6] The International Diabetes Federation recently reported that the 
incidence of DM would increase from 415 million in 2015 to 642 million by 2040, with more 
than 70% of the cases in LMICs.[7] 
 
Although HIV-infection is a leading cause of premature death among adults in sub-Saharan 
Africa (SSA), global NCD trends are mirrored in the region. The trend is evident from the 
rapidly increasing burden of NCDs such as DM and hypertension in SSA countries, giving rise 
to a dual HIV-NCD epidemic.[8] The Global Status Report on NCDs emphasizes that the 
negative impacts of NCDs are particularly severe in poor and vulnerable populations such as 
those living in the  SSA region,[8] where poverty exacerbates many health conditions.[9] In 
SSA, the prevalence of hypertension is increasing with 78% of adults over 55 years living with 
hypertension[10] and prevalence of DM is anticipated to double between 2010 and 2030; with 
28 million people in SSA predicted to be living with the disease.[11]  
 
Since 2003, significant global investment has facilitated the establishment of HIV care services 
in the SSA region. The expansion of and improvements in life-saving antiretroviral therapy 
(ART) has decreased HIV related morbidity and mortality, leading to an ageing population 
living with HIV who are more susceptible to common NCDs such as hypertension. As such, 
management approaches in the region have transitioned from acute and emergency care to 
chronic care, making HIV programmes large-scale chronic disease initiatives. However, 
prevention, care, and treatment services for DM and hypertension remain inaccessible for most 
in SSA, and health systems are rarely designed to provide the continuing services required to 
effectively identify patients at risk, engage them in care, and retain them for long-term 
treatment.[12] Recent research indicates that only 5-20% of people with DM or hypertension 
are thought to be in regular care.[13] Therefore, there is an urgent need to expand the capacity 
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of healthcare systems in SSA to provide services for NCDs such as DM and hypertension. As 
populations are increasingly demonstrating multi-morbidity, such as DM and hypertension 
with HIV,[14] health care providers in SSA countries are now faced with an increasing need 
to manage HIV and NCDs simultaneously. 
 
In the SSA region, as concern about the management of NCDs among people living with HIV 
(PLHIV) increases, the infrastructure and lessons learnt from the HIV chronic disease 
treatment model are important resources for a potential plan to expand and operationalise 
enhanced NCD prevention, care, and treatment.[15] These include health services which are 
stand-alone and vertically delivered and have been combined with decentralisation and task 
shifting, allowing primary health centres to treat large numbers of patients with almost 70% 
of people living with HIV-infection in regular care.[16] Given the similarities between 
chronic communicable and NCDs from the health system and program management 
perspective (their effects on health and individual functioning share common pathways and 
outcomes), the health care systems, tools to diagnose and manage patients, and 
implementation strategies developed to provide continuity of care for HIV in SSA can 
potentially be rapidly, efficiently, and effectively utilized to support patients and services for 
other chronic NCDs.[15] These include decentralised care, task-shifting, counselling, 
community engagement, drugs and diagnostics procurement and treatment adherence support 
for the management of HIV as a chronic condition.[17, 18] However, though a number of 
models of integrated HIV/NCD care have been established in recent years, the lack of 
evidence-based care models for scaling up makes it difficult for SSA countries to develop 
effective policy and implementation of appropriate integration strategies.[19]  
 
We conducted a scoping review to map and describe extant policy and evidence based literature 
in the field, examine the feasibility of integrating care for DM and hypertension with HIV care 
in SSA, and examine how best to leverage infrastructure currently in place for HIV care, for 
the treatment of DM and hypertension. The review is part of the ‘INTE-AFRICA’ European 
Union (EU) funded project[20, 21] which is assessing the effectiveness and feasibility of two 
approaches in Tanzania and Uganda: scale up hypertension and diabetes integrated services 







A methodologically rigorous scoping review framework comprising an iterative six-stage 
process developed by Arksey and O’Malley[22] was adopted to undertake a comprehensive 
search of extant policy and evidence based literature examining the integration of NCD care 
with HIV care in SSA. The six stages of the scoping review process are described below. 
 
Stage 1: Identifying the research question 
 
The objectives of this review were focused on extant knowledge and gaps around the content, 
evaluation, and effectiveness of integrating DM, hypertension and HIV care in SSA. Three 
research questions were developed to guide the review:  
1. What is the existing policy and evidence based literature regarding the integration of 
DM and hypertension with HIV care in SSA? 
2. Is it feasible to integrate care for DM and hypertension with HIV care in SSA? 
3. How can we best leverage HIV care infrastructure for the treatment of DM and 
hypertension in SSA? 
 
Stage 2: Identifying relevant studies 
 
The comprehensive three-step search strategy recommended in standard Joanna Briggs 
Institute (JBI) systematic reviews[23] was utilized in this review in order to identify both 
published and unpublished (grey literature) evidence. The first step was an initial limited search 
of relevant databases such as PubMed, followed by an analysis of the text words contained in 
the title and abstract, and of the index terms used to describe the article. A second search using 
all identified keywords and index terms was then undertaken across all included databases. 
Thirdly, the reference list of all identified reports and articles were manually searched for 
additional relevant studies. Only studies published in English were considered for inclusion in 
this review. No date limitation was imposed upon the search strategies.  
 
Electronic databases searched included: PubMed, Embase, CINAHL, and the Cochrane library. 
Search terms agreed upon, and the general search strategy are outlined in Fig. 1. Citations were 






Figure 1. Search strategy. 
PubMed 










AND (“HIV”[tiab] OR “Human 
immunodeficiency virus”[tiab] OR 
“AIDS”[tiab] OR “Acquired 
immunodeficiency 
syndrome”)[[tiab])) AND (sub-
saharan africa[tiab] OR uganda[tiab] 
OR kenya[tiab] OR 
mozambique[tiab] OR 
swaziland[tiab] OR zambia[tiab] OR 
tanzania[tiab] OR nigeria[tiab] OR 
cameroon[tiab] OR malawi[tiab] OR 
ethiopia[tiab] OR congo[tiab] OR 
lesotho[tiab] OR botswana[tiab] OR 
angola[tiab] OR burundi[tiab] OR 
“central african republic”[tiab] OR 
chad[tiab] OR guinea[tiab] OR 
gabon[tiab] OR rwanda[tiab] OR 
sudan[tiab] OR djibouti[tiab] OR 
eritea[tiab] OR somalia[tiab] OR 
comoros[tiab] OR madagascar[tiab] 
OR mauritius[tiab] OR namibia[tiab] 
OR seychelles[tiab] OR benin[tiab] 
OR mali[tiab] OR “burkina 
faso”[tiab] OR “cape verde”[tiab] 
OR gambia[tiab] OR ghana[tiab] OR 
liberia[tiab] OR niger[tiab] OR 
senegal[tiab] OR “sierra leone”[tiab] 
OR togo[tiab] OR mauritania[tiab] 
OR ivoire[tiab] OR ivory[tiab] OR 
“sao tome”[tiab]) 
 (("Diabetes" OR "Hypertension" OR 
"noncommunicable diseases") AND 
("HIV" OR "Human 





diseases) AND (hiv OR 
aids OR human 
immunodeficiency 
virus OR acquired 
immunodeficiency 
syndrome AND (sub-
saharan africa OR 
uganda OR kenya OR 
mozambique OR 
swaziland OR zambia 
OR tanzania OR nigeria 
OR cameroon OR 
malawi OR ethiopia OR 
congo OR lesotho OR 
botswana OR angola 
OR burundi OR 
“central african 
republic” OR chad OR 
guinea OR gabon OR 
rwanda OR sudan OR 
djibouti OR eritea OR 
somalia OR comoros 
OR madagascar OR 
mauritius OR namibia 
OR seychelles OR 
benin OR mali OR 
“burkina faso” OR 
“cape verde” OR 
gambia OR ghana OR 
liberia OR niger OR 
senegal OR “sierra 
leone” OR togo OR 
mauritania OR ivoire 










TI ( (diabetes OR 
hypertension OR 
"noncommunicable 
diseases") AND ("hiv" 
OR "aids" OR "human 
immunodeficiency 
virus" OR "acquired 
immunodeficiency 
syndrome") AND 
Africa ) OR AB 
( (diabetes OR 
hypertension OR 
"noncommunicable 
diseases") AND ("hiv" 
OR "aids" OR "human 
immunodeficiency 
virus" OR "acquired 
immunodeficiency 
syndrome") AND (sub-
saharan africa OR 
uganda OR kenya OR 
mozambique OR 
swaziland OR zambia 
OR tanzania OR nigeria 
OR cameroon OR 
malawi OR ethiopia OR 
congo OR lesotho OR 
botswana OR angola OR 
burundi OR “central 
african republic” OR 
chad OR guinea OR 
gabon OR rwanda OR 
sudan OR djibouti OR 
eritea OR somalia OR 
comoros OR madagascar 
OR mauritius OR 
namibia OR seychelles 
OR benin OR mali OR 
“burkina faso” OR “cape 
verde” OR gambia OR 
ghana OR liberia OR 
niger OR senegal OR 
“sierra leone” OR togo 
OR mauritania OR 
ivoire OR ivory OR “sao 
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"AIDS" OR "Acquired 
immunodeficiency syndrome")) 
AND ("integrate" OR "integrated" 
OR "integration") AND "Africa" 
AND "Systematic review" OR 




("HIV"[Mesh] OR "Acquired 
Immunodeficiency 
Syndrome"[Mesh]) AND (sub- 
saharan africa OR uganda OR kenya 
OR mozambique OR swaziland OR 
zambia OR tanzania OR nigeria OR 
cameroon OR malawi OR ethiopia 
OR congo OR lesotho OR botswana 
OR angola OR burundi OR central 
african republic OR chad OR guinea 
OR gabon OR rwanda OR sudan OR 
djibouti OR eritea OR somalia OR 
comoros OR madagascar OR 
mauritius OR namibia OR seychelles 
OR benin OR mali OR burkina faso 
OR cape verde OR gambia OR 
ghana OR liberia OR niger OR 
senegal OR sierra leone OR togo OR 
mauritania OR ivoiry OR ivory OR 
sao tome) AND (Systematic Review) 
diseases) AND (hiv OR 
aids OR human 
immunodeficiency 
virus OR acquired 
immunodeficiency 
syndrome) AND (sub-
saharan africa OR 
uganda OR kenya OR 
mozambique OR 
swaziland OR zambia 
OR tanzania OR nigeria 
OR cameroon OR 
malawi OR ethiopia OR 
congo OR lesotho OR 
botswana OR angola 
OR burundi OR 
“central african 
republic” OR chad OR 
guinea OR gabon OR 
rwanda OR sudan OR 
djibouti OR eritea OR 
somalia OR comoros 
OR madagascar OR 
mauritius OR namibia 
OR seychelles OR 
benin OR mali OR 
“burkina faso” OR 
“cape verde” OR 
gambia OR ghana OR 
liberia OR niger OR 
senegal OR “sierra 
leone” OR togo OR 
mauritania OR ivoire 






AND ('article'/it OR 
'review'/it) 
tome”); Limiters – Full 
Text 
TX (diabetes OR 
hypertension OR 
"noncommunicable 
diseases") AND ("hiv" 
OR "aids" OR "human 
immunodeficiency 
virus" OR "acquired 
immunodeficiency 
syndrome") AND (sub-
saharan africa OR 
uganda OR kenya OR 
mozambique OR 
swaziland OR zambia 
OR tanzania OR nigeria 
OR cameroon OR 
malawi OR ethiopia OR 
congo OR lesotho OR 
botswana OR angola OR 
burundi OR “central 
african republic” OR 
chad OR guinea OR 
gabon OR rwanda OR 
sudan OR djibouti OR 
eritea OR somalia OR 
comoros OR madagascar 
OR mauritius OR 
namibia OR seychelles 
OR benin OR mali OR 
“burkina faso” OR “cape 
verde” OR gambia OR 
ghana OR liberia OR 
niger OR senegal OR 
“sierra leone” OR togo 
OR mauritania OR 
ivoire OR ivory OR “sao 
tome”)  AND 
"Systematic Review"; 




#1 MeSH descriptor: [Diabetes Mellitus] explode all trees 
#2 MeSH descriptor: [Hypertension] explode all trees 
#3 MeSH descriptor: [Noncommunicable Diseases] explode all trees 
#4 MeSH descriptor: [HIV] explode all trees 




#6 ((diabetes OR hypertension OR “noncommunicable diseases”) AND (“HIV” OR 
“AIDS” OR “Human immunodeficiency virus” OR “Acquired immunodeficiency 
syndrome”) AND (sub-saharan africa OR uganda OR kenya OR mozambique OR 
swaziland OR zambia OR tanzania OR nigeria OR cameroon OR malawi OR ethiopia 
OR congo OR lesotho OR botswana OR angola OR burundi OR “central african 
republic” OR chad OR guinea OR gabon OR rwanda OR sudan OR djibouti OR eritea 
OR somalia OR comoros OR madagascar OR mauritius OR namibia OR seychelles 
OR benin OR mali OR burkina faso OR cape verde OR gambia OR ghana OR liberia 
OR niger OR senegal OR sierra leone OR togo OR mauritania OR ivoire OR ivory 
OR sao tome) 
#7 (#1 OR #2 OR #3) AND (#4 OR #5) AND (sub-saharan africa OR uganda OR kenya 
OR mozambique OR swaziland OR zambia OR tanzania OR nigeria OR cameroon 
OR malawi OR ethiopia OR congo OR lesotho OR botswana OR angola OR burundi 
OR “central african republic” OR chad OR guinea OR gabon OR rwanda OR sudan 
OR djibouti OR eritea OR somalia OR comoros OR madagascar OR mauritius OR 
namibia OR seychelles OR benin OR mali OR “burkina faso” OR “cape verde” OR 
gambia OR ghana OR liberia OR niger OR senegal OR “sierra leone” OR togo OR 
mauritania OR ivoire OR ivory OR “sao tome) 
Search strategy: #6 OR #7 in Cochrane Reviews and Trials 
 
 
Stage 3: Study selection 
 
The selection process consisted of two levels of screening: (1) a title and abstract review and 
(2) a full-text review. In the first level of screening, the titles and abstracts of identified articles 
were screened for inclusion against a set of minimum inclusion criteria (abstract relevant to the 
topic area). In the second screening, the full text of articles was assessed to determine if they 
meet the inclusion criteria (full text is relevant to the study title). The PRISMA flow diagram 
as illustrated in Fig. 2 outlines the results of the literature search. 
 
Consistent with the scoping review methodology, this study was broad in its inclusion of 
different types of literature.[22, 24, 25] and an assessment of methodological quality was not 
performed to include or exclude studies based on quality scores.[22, 24, 26] Both peer-
reviewed and grey literature were searched, with no methodological requirement for study 
inclusion. This facilitated the inclusion of an array of literature, which included quantitative, 
qualitative and mixed-method studies, as well as systematic reviews and meta-analyses. 
Protocols were excluded as they did not provide evidence required, but where relevant and 
available, studies published based on the protocols identified were screened for inclusion. The 
eligibility criteria for content were developed according to the JBI reviewer’s manual 
9 
 
(2015),[27] which suggests the use of the mnemonic PCC (population, concept, and context) 
to target the desired focus and scope for the review (Table 1)  and the following pre-determined  
exclusion criteria. All criteria had to be met for inclusion/exclusion in the final review. 
 Not in English 
 Not related to the integrated management of NCDs and HIV 
 Not based in sub-Saharan Africa 
 
 
Table 1. PCC Framework 
 
Criteria Determinants 
Population The article had to focus on individuals with NCDs (DM or hypertension) 
and/or HIV, without restrictions on age or sex. 
Concept The article had to describe, evaluate, or propose how NCD management can 
be integrated with HIV management to improve patient outcomes.   
Context The article had to focus on the integration of NCD management with HIV 
management in the context of SSA. 
 
Figure 2. PRISMA flow-diagram of the study selection process of identification, 





Stage 4: Charting the data 
 
To facilitate comparison and thematic analysis the following data were extracted from the 
articles: 
 Author(s), year of publication, title 
 Study setting 
 Study design 
 Target population and diseases 
 Intervention type 
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 Outcomes measured 
 Findings 
 
Stage 5: Charting, summarizing and reporting the results 
 
A thematic analysis was conducted of the charted articles for inclusion in the final review using 
the World Health Organisation (WHO) definition of integrated service delivery.[28] The initial 
thematic analysis was completed by the first author (GM) using Braun and Clarke’s framework 
[29]. Steps 4 and 5 of the framework were then carried out together by the first, second and last 
author.  
 
Two tables were developed to summarize findings from the included studies (Table 2 
(Appendix 1) and Table 3 below). The tables enable better contextualization of what is known 
from the existing literature about how we can best integrate DM and hypertension management 




Table 3. Descriptive characteristics of final included studies (Intervention, Outcomes Measured, Findings) 
 
Author, Year Description of Intervention Outcomes  Measured Findings 
Anand et al., 
2019[30]  
Task-sharing: sharing of tasks with 
other healthcare professionals with 
some supervision/referral to 
physicians 
Population, interventions, blood 
pressure, and task sharing groups 
(Task sharing in LMICs has been useful in managing 
HIV/AIDS) 
 
Task-sharing interventions for managing 
hypertension in LMICs show potential in reducing 
blood pressure 
Chang et al., 
2019[31] 
Integrated chronic disease 
management model for managing 
multimorbidity 
Relationship between type of 
multimorbidity and progression along 
the care continuum; Effect of type of 
multi-morbidity on HIV care among 
HIV patients 
Among HIV patients, presence of cardiometabolic 
conditions was associated with less progress in HIV 
care.  
 
The findings imply that the objective of the ICDM 
model may not yet be realised 
 
George et al., 
2019[32] 
n/a Association between detectable HIV 
viral load and NCD comorbidity 
There is an underdiagnosis of NCDs in HIV patients.  
 
An integrated chronic care system would allow 
enhanced detection, and dual management of HIV 
and NCDs  
Iwelunmor et al., 
2019[33] 
Integrating evidence-based 
hypertension interventions within 
HIV clinics for PLHIV in Nigeria 
Capabilities, Opportunities and 
Motivations for integrating evidence-
based hypertension interventions 
within HIV clinics for PLHIV in 
Nigeria 
Relative capabilities and opportunities were minimal.  
 
There is a need to strengthen the HIV clinics in 
Lagos for the implementation of these interventions 





Integrated chronic care delivery 
model at local health facilities that 
offered treatment for both HIV and 
hypertension  
Primary: Hypertension control at 
follow-up clinic visits 
 
Secondary: Blood pressure control at 2 
consecutive visits separated by at least 
1 month 
Integrated HIV and hypertension care provided under 
the same roof enabled “one-stop” shopping for 
patients.  
 
As hypertension and chronic care for other NCDs is 
integrated with HIV chronic care across SSA, co-
located services, a well-trained workforce, and clinic 
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infrastructure will likely be crucial to successful 
treatment of both 
 
Ojo et al., 
2019[35] 
Integrated CVD-HIV care Concept, taxonomy and alignment of 
feasibility; Specific metrics used in 
feasibility assessment 
Several feasible interventions that integrated 
multilevel CVD and HIV care were identified:  
Multi-disease screening; Referral and linkage to care.  
 
Treatment assessment of feasibility was not 
conducted in a consistent fashion across studies 
 
Ansbro et al, 
2018[36] 
Staff training; locally adapted 
protocols; chronic care files; a revised 
appointment system and patient flow; 
and a new database 
Program processes, effectiveness and 
costs 
NCD care can be integrated into a HIV department and 
outpatient setting in an MSF-supported primary care 
centre by utilising pre-existing structures, and can 
achieve acceptable intermediate clinical outcomes and 
retention rates at a cost that is similar to HIV 
programs.  
 
Ekrikpo et al., 
2018[37] 
n/a Prevalence and correlates of 
hypertension, DM, obesity and 
dyslipidaemia 
High prevalence of CVD risk factors makes it 
imperative to ensure detailed screening for CVD in 
HIV patients at care initiation and at regular intervals 
during follow-up.  
 
An integrated approach to NCD/HIV care may be the 
answer to this double disease burden 
 
Golovaty et al., 
2018[38] 
Integrated home-based HIV–NCD 
testing and counselling conducted by 
lay counsellors trained by a study 
nurse in HIV testing, anthropometric 
measurement, and point-of-care 
NCD screening 
Program micro-costing, no of persons 
tested per day 
Comprehensive home-based HIV-NCD testing and 
counselling results in modest increase in costs with 
the potential to avert NCD death and disability 
 
Haldane et al., 
2018[39] 
Service integration for HIV/AIDS 
with NCDs 
Outcomes of service integration, 
barriers and facilitators to integration 
Several innovative initiatives have been described for 
integrating CVD, hypertension and diabetes services 
with HIV/AIDS services. These highlight the 
importance of using communities as a locus of action 
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for activism, advocacy, accountability and service 
delivery and the importance of partnerships to 
facilitate multidisciplinary collaborations 
 
Juma et al., 
2018[40] 
NCD behavioural change 
communication (BCC) interventions 
Reach, Effectiveness, Adoption, 
Implementation, and Maintenance  
Although data on integrated HIV/NCD health 
promotion efforts is limited, evidence is found to 
support the feasibility of integrating HIV/NCD 
within multi-disease screening campaigns in Uganda, 
Kenya and South Africa  
 
Matanje et al., 
2018[41] 
Integrated HIV/NCD care Availability of policies and programs 
and ongoing interventional processes 
related to integrated HIV/NCD care 
Leveraging highly funded and successful HIV 
programs in SSA that employ proven monitoring and 
evaluation systems will support effective HIV/NCD 
integration program monitoring and provide an 
opportunity to improve equity and access of NCD 
care 
 
Njuguna et al, 
2018[19] 
Models of integrated HIV/NCD care  Challenges/ barriers, facilitators/ 
successors of integrated care models, 
lessons learnt  
Leveraging existing HIV infrastructure to provide 
NCD care to the SSA population is feasible, with 
various approaches possible depending on available 
program capacity.  
 
Future efforts will need to factor in descriptions of 
process metrics and cost-effectiveness to further 
guide implementation, as well as clinical outcomes to 






Integration of diabetes care into 
existing HIV and TB platforms 
Diagnostic and treatment capacity for 
diabetes; Interventions aimed to 
increase capacity; Integration of 
diabetes care into existing HIV 
platforms 
Many challenges remain for chronic diabetes care 
provision.  
Optimizing existing resources by integrating diabetes 
care with other disease platforms e.g. HIV and TB 
care is a great opportunity to improve diabetes 
diagnostic systems, medicines provision, training of 
health personnel, patient empowerment, and tracking 




Patel et al., 
2018[43] 
NCD-HIV integrated programs with 
screening and management 
approaches that are contextually 
appropriate for resource-limited 
settings 
Burden of NCDs among PLHIV in 
LMICs; Current management of the 
diseases 
Improved data collection and surveillance of NCDs 
among PLHIV in LMICs are necessary to inform 
integrated HIV/NCD care models.  
 
Although efforts to integrate care exist, further 
research is needed to optimize the efficacy of these 
programs 
 
Pfaff et al., 
2018[44] 
Integrated HIV-NCD care: blood 
pressure measured at every visit and 
random blood glucose determined 
every 2y in a large HIV clinic 
Patients screened and diagnosed with 
hypertension/diabetes, mean duration 
of ART visits, mean number of patients 
seen a day, challenges of integrated 
HIV-NCD care 
The experience in Zomba demonstrates that the 
strengths of the ART program may be used to 
provide integrated NCD care within HIV settings.  
 
Several challenges related to workload, patient flow, 
monitoring and evaluation and NCD drug shortages 
were encountered during pilot integration 
implementation that are currently being addressed 
and may serve as lessons for wider integration efforts 
 
Rawat et al., 
2018[45] 
Integration of HIV care into primary 
care clinics 
Influence of integrating HIV-care into 
primary health care clinics (PHCCs) on 
quality of NCD care for diabetes and 
hypertension; how changes may relate 
to HIV patient numbers 
The gains in infrastructure and investment in HIV-
care could be leveraged to strengthen, not erode, 
NCD care.  
 
By harmonizing preventive efforts to reduce and treat 
NCDs within the context of HIV-care, countries can 
synergistically advance health and social 
benchmarks.  
 
The growing burden of other NCDs combined with 
the greater life expectancy of people living with HIV 
demand that health systems remain strong to ensure 
that comprehensive HIV-care does not come at the 
expense of screening and treatment for NCDs, 




Ameh et al, 
2017[46] 
Integrated chronic disease 
management (ICDM) model in 
Primary health care facilities 
Health outcomes including patients' 
CD4 counts and blood pressure 
Application of the model had a small effect in 
controlling patients’ CD4 counts and BP, but showed 
no overall clinical benefit for the patients; hence, the 
need to more extensively 
leverage the HIV program for hypertension treatment 
 
Mosha et al., 
2017[47] 
Integrating blood pressure screening 
into a community-based HIV 
screening program 
Prevalence of hypertension and the 
associated factors  
Integration of hypertension screening into routine 
clinics for HIV allowed many undiagnosed cases of 
diabetes and other chronic diseases to be identified.  
 
If combined with proper hypertension treatment, 
consequences such as CVD and stroke can be 
avoided, but this requires improvements of the 
clinical services in health facilities 
 
Pfaff et al., 
2017[48] 
NCD care at EQUIP-affiliated 
facilities (Extending Quality 
Improvement for HIV/AIDS in 
Malawi) 
Current capacity of NCD program, 
using hypertension and diabetes as 
tracer conditions; Extent of integration 
with HIV and ART care 
There is much potential to use lessons from the ART 
program to strengthen NCD care as ART clinics 
represent one of the first screening and primary care 
delivery models for chronic disease in Africa, 
supported by health information, short course 
training and supervision 
 
Shankalala et al., 
2017[49] 
n/a Proportion with impaired fasting 
glucose or DM 
High levels of impaired fasting glucose or DM 
among cART patients compared to what is reported, 
suggesting missed care and support opportunities.  
 
There is a need to repackage HIV programming to 
include integration of diabetes screening as part of 
the overall care and support strategy 
 
Divala et al, 
2016 
n/a Proteinuria, non-fasting lipids and 
cardio/cerebro-vascular disease (CVD) 
risk scores 
Integrated HIV-hypertension-diabetes care may be 
individually beneficial but increases the burden of 




Excluding patients with mild hypertension and low 
CVD risk from drug treatment would half the overall 
burden of HIV patients in need of integrated 
pharmacotherapy for diabetes and/or hypertension 
 
Fairall et al., 
2016[50] 
Primary Care 101 (PC101) 
leveraging health system 
reforms accompanying the scale-up 
of antiretroviral therapy (ART) to 
improve  
quality of primary care for other 
priority conditions e.g. NCDs 
Treatment intensification for 
hypertension, diabetes, and chronic 
respiratory disease; case detection of 
depression 
Educational outreach to primary care nurses to train 
them in the use of a management tool involving an 
expanded role in managing NCDs was feasible and 
safe but was not associated with treatment 
intensification or improved case detection for index 
diseases. 
 
However, the intervention, with adjustments to 
improve its effectiveness, has been adopted for 
implementation in primary care clinics throughout 
South Africa 
 
Rachlis et al., 
2016[51] 
Chronic disease care for HIV, TB 
and hypertension as part of the 
Academic Model Providing Access 
to Healthcare (AMPATH) program  
Barriers and facilitators to linkage and 
retention 
Integrated service delivery for chronic diseases may 
support timely engagement in care given the 
increasing prevalence of NCDs among the general 
population and HIV patients.  
 
However, such models should be rigorously 
evaluated to explore their acceptability and potential 
negative impacts, and should be tailored for specific 
contexts and settings, and support individuals with 
logistical and financial challenges 
 
Some et al., 
2016[52] 
Task-shifting the management of 
NCDs from clinical officers to 
nurses who also manage routine 
primary and HIV care 
Adherence to Médecins Sans Frontières 
clinical protocols 
Nurses working within a resource-constrained, 
primary care and HIV setting, can successfully 
follow protocols managing stable patients with 




This approach could be applied in other similar HIV-
based programs to extend access to areas with 
increasing need of NCD care and limited resources 
 
Edwards et al, 
2015[53] 
n/a Patient demographics, clinical 
characteristics, disease prevalence 
PLHIV are at higher risk of developing concurrent 
NCDs at a younger age and would benefit from 
routine screening and treatment.  
 
Treatment appears to produce results comparable to 
patients without HIV.  
 
It also demonstrates that it is possible to integrate 
both HIV and NCD care together in a primary care 
program that is largely run by clinical 
officers and nursing staff within significant resource 
constraints.  
 
This model may be useful in the scale-up of NCD 
care in sub-Saharan Africa in the future 
 
Haregu et al., 
2015[54] 
HIV-NCD integration Rationale, policy bases and models of 
HIV-NCD integration 
Models of HIV-NCD integration that were “tested” 
in the context of developing countries vary but all 
models indicated that the integrated approach was 
feasible, effective, efficient and acceptable. However, 
overall evidence is limited and context-specific 
evidence is lacking 
 
Khabala et al, 
2015[55] 
Combined MACs: Nurse-facilitated 
groups of 25-35 stable hypertension, 
diabetes and HIV patients with 
quarterly follow-ups 
Correctly completed blood pressure, 
weight and laboratory testing during 
MAC attendance, adherence, referral to 
clinic, retention 
This study demonstrates the feasibility and early 
efficacy of Medication Adherence Clubs as a novel 
group treatment model to care for stable patients with 
mixed chronic diseases in an urban, resource-




It supports reducing the burden of regular clinical 
follow-up among stable patients and improves the 





Integrated chronic disease 
management (ICDM) model using a 
health systems approach 
Feasibility of integration, Challenges The implementation of the integrated chronic disease 
management model is feasible at primary care in 
South Africa provided that systemic challenges and 
change management are addressed during the 
implementation process 
 
Joshi et al., 
2014[57] 
Task-shifting the management of 
NCDs from physicians to non-
physician healthcare workers 
(NPHWs)  
Viability, Cost-effectiveness, Clinical 
effectiveness 
Task shifting has proved to be a viable and cost-
effective option for the management of HIV-AIDS in 
SSA. 
 
Task-shifting, if accompanied by health system 
restructuring, is a viable and potentially effective and 




n/a Yield of new diagnosis, CD4 count 
testing, linkage to care, correlates of 
linkage and barriers to care 
Integrated HIV, TB symptoms and NCD screening in 
mobile units holds promise for expanding the scope 
of HIV services and the reach of primary healthcare 
 
Chamie et al, 
2012[59] 
A five-day, multi-disease campaign, 
offering diagnostic, preventive, 
treatment and referral services 
 
Community-based HIV and NCD 
testing campaigns offering 
diagnostic, preventive, treatment and 
referral services compared with 
routine service delivery methods 
Community participation, case-finding 
yield, and linkage to care 
 
Feasibility and diagnostic yield of 
integrating NCD into a rapid 
community-based multidisease 
screening campaign 
In an integrated campaign engaging 74% of adult 
residents, a high burden of undiagnosed HIV,  
hypertension and diabetes was identified.  
 
The campaign demonstrates the feasibility of 
integrating hypertension, diabetes and communicable 
diseases into HIV initiatives 
 
Rabkin et al., 
2012[18] 
Intervention package adapted and 
implemented from HIV program to 
support diabetes services in the 
outpatient department. 
Site assessments, chart review, and 
health care worker questionnaires. 
Countries which have successfully scaled up HIV 
services have already learnt profound lessons about 




Using locally owned and contextually appropriate 
resources may be an efficient and effective way to 
“jumpstart” NCD programs and to strengthen health 
systems 
 
Van Olmen et 
al., 2012[60] 
Models of care delivery and 
treatment of diabetes and HIV/AIDS 
The disease dimension,” the “health 
provider dimension,” the patient or 
“person dimension,” and the 
“environment dimension” of chronic 
diseases.  
 
Lessons from present care models for HIV/AIDs and 
DM show potential for cross-fertilization between 
models: rapid scale-up approaches through the public 
health approach by simplification and 
decentralisation; community involvement, peer 
support and self-management strategies; and 
strengthening health services 
 
Levitt et al., 
2011[61] 
Integration of primary level care for 
people with NCDs and those 
receiving ART 
Health care implications of colliding 
HIV/NCD epidemics, Argument for an 
integrated model of care 
The current vertical program for HIV/AIDS care and 
that for NCDs, which take place within a chaotic 
primary care system, should be replaced by 
integrated care for patients with any chronic disease, 
in a coherent patient-centred program  
Integrated chronic disease care services in primary 
care facilities should be separated from acute care 
services, naturally with sufficient coordination 
between the two forms of care to ensure that patients 
can move freely between acute and chronic care 
services when required 
 
Lekoubou et al., 
2010[62] 
Task shifting to nurses: Nurse-led 
strategies for chronic disease 
management 
Surrogates of disease control Task sharing in LMICs has been useful in managing 
HIV/AIDS. 
 
Task-shifting has been implemented in a few 
countries in SSA with some indicators of success in 
chronic disease care.  
 
With regard to hypertension and diabetes, limited 
available evidence suggests that acceptably designed 
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task-shifting interventions are feasible and useful for 
their care in SSA 
 
Maher et al., 
2010[63] 
Primary care-delivery for both CDs 
and NCDs 
Ways primary care can respond to the 
health transition to a double burden of 
CDs and NCDs in Africa 
Primary care is well placed to offer a coherent 
response to the problems of both CDs and NCDs.  
 
National and international alliances have a key role to 
play in mobilizing necessary investments for an 
effective primary-care response to the health transition 
in Africa. 
 
*PLHIV – People living with HIV 




Stage 6: Consultation with stakeholders 
 
The 209 records identified in the initial database search were shared with members of the 
‘INTE-AFRICA’ consortium[20, 21] which resulted in an additional 22 records being 
suggested. 
 
Patient and Public Involvement 
 







The initial database search identified 209 records. These, along with an additional 22 records 
suggested by the steering group which were not identified in the initial database search, gave a 
total of 231 records which were considered for inclusion in this review. After 12 duplicate 
records were removed, reviewers screened the remaining 219 records by title and abstract, 
during which 165 records were excluded for reasons showed in Fig. 2. Fifty-four articles met 
the inclusion criteria and were selected for full-text review. Following full-text review, 16 
records were excluded due to a lack of relevance or the unavailability of the full text article 
(Fig. 2), leaving 37 records which were identified to be relevant to the integration of NCDs 
management with HIV management in Africa. The search process, as guided by the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), is summarised in Fig. 
2. Data were extracted from a final selection consisting of 37 records which met the eligibility 
criteria for the review.  
 
Description of Included Studies 
 
The 37 records included examined various aspects related to the integration of HIV and NCD 
care in SSA. The records included studies that examined the feasibility of integrating care for 
DM and hypertension with HIV care, as well as studies that examined how best to leverage the 
infrastructure and lessons learnt from providing HIV care to enhance the treatment of DM and 
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hypertension. Both quantitative and qualitative studies were included, with no restriction on 
study design, to allow us to map the field and aquirea sense of the extant literature available on 
the topic of HIV/NCD care integration in SSA. Papers included were published between 2010 
and 2019, and study locations included Kenya, South Africa, Swaziland, Tanzania, and 
Uganda. General characteristics of the included studies are summarized in Table 2 (Appendix 
1) and Table 3.  
 
Mapping the Field – Extent and Nature of Extant Literature  
 
Despite no limitations being placed on publication date in our database searches, the earliest 
included record was published in 2010. This is understandable, given that integrated HIV/NCD 
management remains a relatively new area of interest, with the emerging NCD epidemic in 
SSA only more recently being put under the national and global spotlight, in contrast to the 
longstanding HIV epidemic that has been recognized for over three decades.  
 
With no limitations being placed on the study design of records included in this review, the 
included records adopted a wide range of methodologies. Of the 37 records, 13 were 
observational studies, including cross-sectional studies, case-control studies, as well as 
retrospective and prospective cohort studies. Eight were interventional studies, including pre-
post studies, non-randomized trials, and randomized controlled trials. Two were mixed 
methods studies, two were qualitative studies, and 13 were reviews, including systematic 
reviews, scoping reviews and narrative reviews. Study designs of included records are 




Studies included identified various aspects of integrating NCD care into HIV care, which can 
be broadly classified into three themes: (1) Evaluation of HIV/NCD Care Integration, (2) 
Arguments for Integrated HIV/NCD Care, and (3) Effectiveness of Task-Shifting/Sharing for 
NCD Care Delivery. The themes explored by the included records are summarized in Table 2 
(Appendix 1). 
 




Of the 37 records, 24 evaluated various aspects of HIV/NCD Care Integration. These can be 
further classified into three sub-themes: ‘Current Policies and Integration Models: Summary/ 
Review’, ‘Feasibility: Capacity, Clinical- and Cost-effectiveness’, and ‘Facilitators and 
Barriers to Integration’. These sub-themes are not mutually exclusive, with some records 
falling under two or indeed all of the three subthemes.  
 
Current Policies and Integration Models Summary/Review 
Seven of the 24 records under this theme summarized and reviewed various policies and models 
related to integrated HIV/NCD management that are currently in place in various African 
countries. Of these seven studies, one was an observational study,[41] one was a mixed- 
methods study,[48] one was a qualitative study,[54] and four were review papers.[19, 39, 40, 
42] The seven records reported studies in various SSA countries, including Kenya, Malawi, 
South Africa and Swaziland. Two of the seven records summarized and reviewed current 
policies in place in SSA countries for HIV/NCD integration.[41, 54] These studies highlighted 
National stakeholders were supportive of integrated policy development, however 
inconsistencies in implementation  where evident between countries. Evidence gaps for cost-
effectiveness, effects of integration on key HIV and NCD outcomes and funding mechanisms 
for sustained implementation of integrated HIV/NCD care strategies, were among challenges 
identified. All seven records summarized and reviewed current HIV/NCD care integration 
models in SSA countries.[19, 39-42, 48, 54] These included integrated community-based 
screening for HIV and NCDs in the general population; screening for NCDs and NCD risk 
factors among HIV patients enrolled in care; integration of HIV and NCD care within clinics; 
differentiated care for patients with HIV and/or NCDs; and population healthcare for all. The 
studies acknowledged integration models are in their infancy, resulting in a lack of clinical and 
process outcomes data, and a lack of cost-effectiveness data from the various models. 
 
Feasibility: Capacity, Clinical- and Cost-effectiveness 
All 24 records under this theme evaluated the feasibility of integrated HIV/NCD management 
in SSA countries. These records discussed aspects such as the capacity of current HIV clinics 
to provide integrated care, as well as clinical- and cost-effectiveness of integrated care.  Of 
these 24 studies, seven were observational studies,[31, 36, 38, 41, 47, 53, 64] seven were 
interventional studies,[18, 34, 44-46, 56, 59] two were mixed methods studies,[33, 48] two 




Four of the 24 records examined the capacity of HIV/ART clinics to accommodate integrated 
NCD care into care delivery.[33, 41, 42, 48] Studies indicated that HIV / ART programmes 
have developed considerable systems innovations which could accommodate NCD care. 
Nineteen records assessed the clinical effectiveness of integrated HIV/NCD care. For the 
purposes of this study, studies focusing on patient-centred outcomes such as: population 
penetrance,[35, 40] disease control as measured using surrogate disease markers,[34-36, 39, 
42, 46, 53] linkage and retention in care,[19, 35, 36, 42, 51, 54, 59, 64] quality of care (wait-
time, service delivery, comprehensiveness and continuity of care etc.) and patient 
satisfaction,[18, 19, 31, 39, 40, 42, 44, 54, 56] treatment adherence,[40, 42, 54] and diagnostic 
yield[19, 35, 39, 40, 42, 45, 47, 53, 59, 64] are classified as studies assessing “clinical 
effectiveness”. Most of the studies concluded in favour of the clinical effectiveness of 
integrated HIV/NCD care in view of improvements that were achieved in the above-mentioned 
patient-centred outcomes. These included screening for NCDs within HIV care programmes 
which improve the identification of undiagnosed NCDs among patients living with HIV and a 
reduction in duplication and fragmentation of services, which increase efficiency 
of resource use and help patients remain in care. Five records examined the cost-effectiveness 
of integrated HIV/NCD care.[34, 36, 38, 40, 59]  These studies support the cost-effectiveness 
of HIV/NCD integration efforts while highlighting the additional time burden of NCD 
screening and testing along with human resources and drugs prices as the major driver of costs.  
 
Facilitators and Barriers to Integration 
Seventeen of the 24 records under this theme identified various facilitators and barriers to 
integrating or to achieving efficient integrated HIV/NCD care. Of these 17 records, four were 
observational studies,[31, 36, 41, 53] five were interventional studies,[18, 44-46, 56] two were 
mixed methods studies,[33, 48] and six were review papers.[19, 35, 39, 40, 42, 43]  
 
Table 4. Barriers and facilitators to integrated HIV/NCD care 
Barriers Facilitators 
The lack of diagnostic equipment and 
medication[18, 19, 31, 35, 36, 39, 42-46, 48, 
53, 56] 
Task-shifting/task-sharing[19, 42, 43] 
Lack of trained staff or training[18, 31, 35, 
36, 39-43, 46, 48, 53, 56] 
Utilization of existing trained staff or 
infrastructure[19, 31, 35, 39, 40, 42, 45, 48] 
Overburden from an increased workload[19, 
36, 39, 40, 43-46, 48, 56] 
The perceived benefits of integrated 
care[35, 43, 44, 48] 
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Evidence gaps[40-43] Favourable policy environment and 
governmental support[19, 35, 41] 
Insufficient funding[19, 35, 40, 41, 48] Reorganization of patient flow[19, 44] 
Lack of guidelines and operating 
protocols[18, 53] 
 
Perceived threat of integration to existing 




(2) Arguments for Integrated HIV/NCD Care 
 
Eight of the 37 included records put forth arguments for integrated HIV/NCD care. Of these 
eight records, four were observational studies,[32, 37, 49, 65] and four were review 
papers.[19, 60, 61, 66] The four observational studies[32, 37, 49, 65] and one review 
paper[60] examined the prevalence of either NCDs,[32, 49, 65] CVD risk factors[37, 65] in 
PLHIV in SSA countries such as Malawi, Nigeria, South Africa and Zambia. All five studies 
found a high prevalence of these conditions in PLHIV, and proposed integrated care as a 
solution to provide holistic chronic care, enhance detection and management of the diseases, 
enhance NCD prevention, as well as to reduce cost and increase efficiency in a resource-
limited setting. The three remaining review papers considered the consequences of the rising 
dual epidemics on the organization of care and potential bridges between the care of these 
diseases.[60] [61] [66]. Overall, studies indicated  HIV/NCD care integration is a feasible 
approach to health system strengthening in SSA but must be context specific. Njuguna et al. 
used case studies to demonstrate a variety of HIV/NCD integration models which programs 
can adopt and adapt based on available resources, needs and priorities. These included the 
creation of curricula to produce integrated chronic care providers instead of specific staff 
dedicated only to HIV or NCD roles and decentralisation to bring care closer to patients to 
minimize logistical barriers to access, while reducing congestion at ‘central’ health facilities. 
 
 
(3) Effectiveness of Task-Shifting/Sharing for NCD Care Delivery 
 
Six of the 37 included records evaluated the effectiveness of various task-shifting/task-sharing 
interventions for NCD care delivery. Of these six records, two were observational studies,[52, 
55] one was an interventional study,[50] and three were review papers.[30, 57, 62] Task-
shifting is defined as the rational movement of primary care duties from physicians to non-
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physician health-care workers (NPHWs), whereas task-sharing is a planned strategy in which 
a team of health-care professionals work together to deliver a service, accompanied by training 
or certification and support for health-care workers.[30] These strategies have been employed 
in developing countries, in particular in the SSA region, with compelling evidence on 
feasibility and indicators for success for various disease entities and health sectors including 
HIV, TB, mother and child health,[62] and to a lesser extent, NCDs,[52] and have been 
recommended by  WHO for low and middle income countries, due to their low health care 




Summary of key findings 
 
The review sought to answer three research questions:  
1. What is the existing policy and evidence based literature regarding the integration of DM 
and hypertension with HIV care in SSA? 
Several studies identified different models of HIV-NCD service integration.[19, 60, 61] These 
include NCD prevention and control incorporated into existing HIV services; HIV prevention 
and control added to primary healthcare already providing NCD services, and simultaneous 
introduction of integrated HIV and NCD services. In terms of existing policy, studies show that 
National stakeholders, led by Ministries of Health (MOH), are supporting HIV/NCD 
integration policy development and implementation through evidence generation and 
coordination activities [41, 54]. However, the degree to which the push for HIV/NCD 
integration is reflected in national level policy documents varies geographically.  
 
2. Is it feasible to integrate care for DM and hypertension with HIV care in SSA? 
The review indicates that integrated HIV/NCD care in the SSA region is challenging but 
potentially feasible. However, studies highlight there remain various country specific, 
contextual, human resource, logistical and infrastructural barriers that need to be considered in 
order to best achieve efficient and effective integrated care delivery. [33, 35, 36] One way of 
overcoming the manpower and infrastructural strain due to the acute shortage of trained health 
staff in SSA, would be through task-shifting, which has proven feasible as an alternative to 
rapidly increase the health workforce[30]. This will require enhanced focus on NCD training 
cascade in integrated services. From the studies included in this review it is not possible to 
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reach a definitive conclusion on whether it is feasible to integrate care for DM and hypertension 
with HIV care in SSA.  Further research is required to generate evidence on the benefits, 
challenges and cost-effectiveness of integration of HIV and NCD services, particularly in those 
countries where NCD services are still developing. 
 
 
3. How can we best leverage HIV care infrastructure for the treatment of DM and 
hypertension in SSA? 
While the review indicates multiple ways in which to leverage the lessons and resources of 
HIV programs when working to expand and enhance DM and NCD services in SSA, it also 
emphasises no single approach is likely to work in all settings. In some countries, integration 
of chronic disease services for HIV and NCDs at the point of care may be an effective approach. 
[46] In other settings this may be neither feasible nor desirable. Studies suggest that countries 
which have successfully scaled up HIV services have already learned profound lessons about 
the delivery of chronic care. Using these locally owned and contextually appropriate resources 
may be an efficient and effective way to kickstart NCD programs and to strengthen health 
systems to support longitudinal services for all. [18, 41, 65]  
 
 
How this review relates to other literature 
 
Although this topic has been studied before [37, 49, 65], the best practices in integrated care 
provision for the prevention, identification and treatment of hypertension, diabetes and HIV 
in SSA have yet to be identified.  While the potential benefits of HIV-NCD integration for 
the health system and patients are well documented,[67, 68] consistent with this review, 
research indicates differences in health systems preparedness to reconfigure the health system 
environment when it comes to chronic care delivery among the diverse SSA countries make 
implementing an integrated care model for HIV-NCD challenging.[69] The majority of 
models of HIV/NCD integration that have been trialled or implemented in SSA in this review 
and the wider literature have highlighted the need for integration programs to be context-
specific, with no single approach likely to work in all settings.[70]  
 .  Therefore, an enhanced contextual understanding of integration is further warranted. Service 
experience and patient outcomes are very dependent on understanding cultures and contexts 
surrounding integrated service design, and the inputs and actions of policy makers, healthcare 
providers, clinicians, patients, communities and international donors With these in mind, the 
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policymakers at national and regional levels can then devise a contextually appropriate strategy 
that maximises existing resources and leverages upon the strengths of the local health system 
while preventing, and prevailing cracks from hurting hard-earned HIV gains and quality of 
clinical care. 
 
Implications for research and policyWhile the quantity and quality of research on integrated 
HIV/NCD care are and have been steadily increasing over the past decade, there remains 
limited evidence about integration both in terms of scope and generalizability of the 
evidence.[16] Existing evidence is limited to small scale feasibility studies in largely different 
contexts, lacking large scale or randomized and/or controlled evaluations.[71] There is also a 
general lack of clinical and process outcomes data, and of cost-effectiveness data from the 
various models, which are often required prior to large-scale HIV/NCD intervention programs 
being rolled out. In addition, context-specific evidence needed to adapt an integrated care 
model that is best suited to the needs of a specific country is lacking. These evidence gaps are 
often cited as a barrier to integration in SSA countries, suggesting an urgent need to fill these 
gaps to further inform implementers and policymakers. Hence, further research is warranted to 
gather not just more, but higher quality evidence on outcomes and cost through randomized 
controlled trials, as well as country-specific evidence at operationalisation and scale up over 
time. Evidence on regional, national and subnational context-specific variations in burden of 
NCDs in PLHIV should inform policy decisions, priority-setting and resource allocation, while 
evidence on the impact of HIV/NCD integration on the existing HIV care model should inform 
policymakers on the likely effects of integration on HIV targets, indicators and systems. Efforts 
should further concentrate on both HIV and NCD awareness raising tactics and prevention 
activities. Additionally, further research is required to understand public understanding of the 
HIV/NCD burden of disease and integration of services, understand and respond to the scaleup 
process and determine the sustainability of integrated care models. It is the aim of the ‘INTE-
AFRICA’ project[20, 21] to address these evidence gaps, along with the various barriers to 
integration identified in this review by conducting a randomised control trial, health economic 







Several limitations should be considered when interpreting the findings of this review. Whilst 
we adopted the rigorous scoping review methodology and used a comprehensive search 
approach, there is a possibility that not all publications relevant to the inclusion criteria were 
identified by the searches or databases used. Scoping reviews do not include an assessment of 
study quality as the focus is on covering the range of work that informs the topic rather than 
limiting the work to studies that meet particular standards of scientific rigour. Finally, only 
articles published in English were considered for inclusion in our review, which could have 
resulted in the exclusion of equally relevant literature published in other languages used in the 





Our review illustrates that HIV/NCD care integration in sub-Saharan Africa is potentially 
feasible, with several models available that countries can adopt and adapt based on available 
resources, needs, and priorities. However, it is important to note that existing evidence is 
largely limited to small-scale feasibility studies in varying contexts, with a paucity of higher 
quality research measuring clinical outcomes, cost-effectiveness and the sustainability of such 
integration. Conducting high quality trials and implementing their findings will enable the 
optimization of existing resources and enhance the outcomes of NCD detection, treatment and 
care for all patients in a manner that is both cost-effective, and which does not weaken the well-




We thank our colleagues on the INTE-AFRICA Work Package 3 Project Steering Group who 
have contributed to the design and write up of this review. In addition, we are grateful to the 
European Commission who funded this project through the Horizon 2020 Programme. JVL 
acknowledges support by a Spanish Ministry of Science, Innovation and Universities 
Miguel Servet grant (Instituto de Salud Carlos III/ESF, European Union [CP18/00074]). 
JVL further acknowledges support from the Spanish Ministry of Science, Innovation and 
Universities through the “Centro de Excelencia Severo Ochoa 2019-2023” Programme 







1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk 
assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 
regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 
2012;380(9859):2224-60. 
2. GBD 2013. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 
240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. 
The Lancet. 2015;385(9963):117-71. 
3. World Health Organization. A global brief on hypertension: silent killer, global public health crisis: 
World Health Day 2013. World Health Organization; 2013. 
4. Allen L, Cobiac L, Townsend N. Quantifying the global distribution of premature mortality from 
non-communicable diseases. Journal of Public Health. 2017;39(4):698-703. 
5. World Health Organization. Noncommunicable diseases: progress monitor 2017. 
6. World Health Organization. Global report on diabetes: World Health Organization. Geneva; 2016. 
7. International Diabetes Federation. IDF Diabetes Atlas. Brussels; 2015. 
8. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health 
Organization; 2008. 
9. World Health Organization. Global status report on noncommunicable diseases 2014. World Health 
Organization; 2014. 
10. Ibrahim MM, Damasceno A. Hypertension in developing countries. The Lancet. 
2012;380(9841):611-9. 
11. Sicree R, Shaw J, Zimmet P. Diabetes Atlas International Diabetes Federation. Belgium: 
International Diabetes Federation; 2006. 
12. Pastakia SD, Pekny CR, Manyara SM, Fischer L. Diabetes in sub-Saharan Africa - from policy to 
practice to progress: targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes. 
2017;10:247-63. 
13. Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-Saharan 
Africa: from clinical care to health policy. The Lancet Diabetes & Endocrinology. 2017;5(8):622-67. 
14. Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of non-communicable and infectious 
diseases in low-and middle-income countries. International journal of epidemiology. 2012;42(1):221-
7. 
15. Rabkin M, Melaku Z, Bruce K, Reja A, Koler A, Tadesse Y, et al. Strengthening health systems for 
chronic care: leveraging HIV programs to support diabetes services in Ethiopia and Swaziland. Journal 
of tropical medicine. 2012;2012. 
16. Van Hout M-C, Bachmann M, Lazarus JV, Shayo EH, Bukenya D, Picchio CA, et al. Strengthening 
integration of chronic care in Africa: protocol for the qualitative process evaluation of integrated HIV, 
diabetes and hypertension care in a cluster randomised controlled trial in Tanzania and Uganda. BMJ 
open. 2020;10(10):e039237. 
17. El-Sadr WM, Goosby E. Building on the HIV platform: tackling the challenge of noncommunicable 
diseases among persons living with HIV. Aids. 2018;32:S1-S3. 
18. Rabkin M, Melaku Z, Bruce K, Reja A, Koler A, Tadesse Y, et al. Strengthening Health Systems 
for Chronic Care: Leveraging HIV Programs to Support Diabetes Services in Ethiopia and Swaziland. 
Journal of Tropical Medicine. 2012;2012:6. 
19. Njuguna B, Vorkoper S, Patel P, Reid MJA, Vedanthan R, Pfaff C, et al. Models of integration of 
HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. 
Aids. 2018;32 Suppl 1:S33-s42. 
20. INTE-AFRICA  [Available from: https://inteafrica.org/. 
21. Shayo E, Van Hout MC, Birungi J, Garrib A, Kivuyo S, Mfinanga S, et al. Ethical issues in 
intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan 
Africa. BMJ Global Health. 2020;5(7). 
32 
 
22. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International journal 
of social research methodology. 2005;8(1):19-32. 
23. Aromataris E, Riitano D. Constructing a search strategy and searching for evidence. A guide to the 
literature search for a systematic review. Am J Nurs. 2014;114(5):49-56. 
24. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology.  Implement Sci. 
52010. p. 69. 
25. Pham MT, Rajic A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA. A scoping review of 
scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods. 
2014;5(4):371-85. 
26. Brien SE, Lorenzetti DL, Lewis S, Kennedy J, Ghali WA. Overview of a formal scoping review on 
health system report cards. Implement Sci. 2010;5:2. 
27. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting 
systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141-6. 
28. World Health Organisation (WHO). Integrated care models: an overview. Health Services Delivery 
Programme, Division Of Health Systems and Public health; 2016. 
29. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 
2006;3(2):77-101. 
30. Anand TN, Joseph LM, Geetha AV, Prabhakaran D, Jeemon P. Task sharing with non-physician 
health-care workers for management of blood pressure in low-income and middle-income countries: a 
systematic review and meta-analysis. The Lancet Global Health. 2019;7(6):e761-e71. 
31. Chang AY, Gómez-Olivé FX, Manne-Goehler J, Wade AN, Tollman S, Gaziano TA, et al. 
Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa. 
Bulletin of the World Health Organization 2019;97(1):10-23. 
32. George S, McGrath N, Oni T. The association between a detectable HIV viral load and non-
communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, 
South Africa. BMC Infectious Diseases. 2019;19(1):348. 
33. Iwelunmor J, Ezechi O, Obiezu-Umeh C, Gbajabiamila T, Musa AZ, Oladele D, et al. Capabilities, 
opportunities and motivations for integrating evidence-based strategy for hypertension control into HIV 
clinics in Southwest Nigeria. PloS one. 2019;14(6):e0217703-e. 
34. Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J, et al. Hypertension 
control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public 
Health. 2019;19(1):511. 
35. Ojo T, Lester L, Iwelunmor J, Gyamfi J, Obiezu-Umeh C, Onakomaiya D, et al. Feasibility of 
integrated, multilevel care for cardiovascular diseases (CVD) and HIV in low- and middle-income 
countries (LMICs): A scoping review. PLoS One. 2019;14(2):e0212296. 
36. Ansbro É, Meyer I, Okello V, Verdecchia M, Keus K, Piening T, et al. Evaluation of NCD service 
integrated into a general OPD and HIV service in Matsapha, Eswatini, 2017. 2018. 
37. Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. Prevalence and correlates 
of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-
sectional study. BMJ open. 2018;8(7):e019664. 
38. Golovaty I, Sharma M, Van Heerden A, van Rooyen H, Baeten JM, Celum C, et al. Cost of 
Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in 
South Africa. Journal of acquired immune deficiency syndromes 2018;78(5):522-6. 
39. Haldane V, Legido-Quigley H, Chuah FLH, Sigfrid L, Murphy G, Ong SE, et al. Integrating 
cardiovascular diseases, hypertension, and diabetes with HIV services: a systematic review. AIDS Care. 
2018;30(1):103-15. 
40. Juma K, Reid M, Roy M, Vorkoper S, Temu TM, Levitt NS, et al. From HIV prevention to non-
communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review. Aids. 
2018;32 Suppl 1:S63-s73. 
41. Matanje Mwagomba BL, Ameh S, Bongomin P, Juma PA, MacKenzie RK, Kyobutungi C, et al. 
Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care 
policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya. Aids. 2018;32 Suppl 
1:S21-s32. 
42. Nuche-Berenguer B, Kupfer LE. Readiness of Sub-Saharan Africa Healthcare Systems for the New 
Pandemic, Diabetes: A Systematic Review. Journal of Diabetes Research. 2018;2018:9262395. 
33 
 
43. Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. 
Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: 
a systematic review and meta-analysis. Aids. 2018;32 Suppl 1:S5-s20. 
44. Pfaff C, Singano V, Akello H, Amberbir A, Berman J, Kwekwesa A, et al. Early experiences 
integrating hypertension and diabetes screening and treatment in a human immunodeficiency virus 
clinic in Malawi. International Health. 2018;10(6):495-501. 
45. Rawat A, Uebel K, Moore D, Yassi A. Integrated HIV-Care Into Primary Health Care Clinics and 
the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, 
South Africa Over 4 Years. Journal of acquired immune deficiency syndromes 2018;77(5):476-83. 
46. Ameh S, Klipstein-Grobusch K, Musenge E, Kahn K, Tollman S, Gomez-Olive FX. Effectiveness 
of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted 
Time-Series Analysis. Journal of acquired immune deficiency syndromes 2017;75(4):472-9. 
47. Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, et al. Prevalence,awareness and 
factors associated with hypertension in North West Tanzania. Global Health Action. 
2017;10(1):1321279. 
48. Pfaff C, Scott V, Hoffman R, Mwagomba B. You can treat my HIV - But can you treat my 
blood pressure? Availability of integrated HIV and non-communicable disease care in northern Malawi. 
African Journal of Primary Health Care Family Medicine. 2017;9(1):e1-e8. 
49. Shankalala P, Jacobs C, Bosomprah S, Vinikoor M, Katayamoyo P, Michelo C. Risk factors for 
impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province 
of Zambia. Journal of Diabetes & Metabolic Disorders 2017;16:29. 
50. Fairall LR, Folb N, Timmerman V, Lombard C, Steyn K, Bachmann MO, et al. Educational 
Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease 
Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial. PLoS 
Medecine 2016;13(11):e1002178. 
51. Rachlis B, Naanyu V, Wachira J, Genberg B, Koech B, Kamene R, et al. Identifying common 
barriers and facilitators to linkage and retention in chronic disease care in western Kenya. BMC Public 
Health. 2016;16:741. 
52. Some D, Edwards JK, Reid T, Van den Bergh R, Kosgei RJ, Wilkinson E, et al. Task Shifting the 
Management of Non-Communicable Diseases to Nurses in Kibera, Kenya: Does It Work? PLoS One. 
2016;11(1):e0145634. 
53. Edwards JK, Bygrave H, Van den Bergh R, Kizito W, Cheti E, Kosgei RJ, et al. HIV with non-
communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010-
2013. Transactions of the Royal Society of Tropical Medicine and Hygiene 2015;109(7):440-6. 
54. Haregu TN, Setswe G, Elliott J, Oldenburg B. Integration of HIV/AIDS and noncommunicable 
diseases in developing countries: rationale, policies and models. International Journal of Healthcare 
2015;1:21-7. 
55. Khabala KB, Edwards JK, Baruani B, Sirengo M, Musembi P, Kosgei RJ, et al. Medication 
Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple 
chronic diseases in informal settlements. Tropical Medicine International Health 2015;20(10):1265-70. 
56. Mahomed OH, Asmall S. Development and implementation of an integrated chronic disease model 
in South Africa: lessons in the management of change through improving the quality of clinical practice. 
International Journal of Integrated Care 2015;15:e038. 
57. Joshi R, Alim M, Kengne AP, Jan S, Maulik PK, Peiris D, et al. Task shifting for non-communicable 
disease manageement in low and middle income countries--a systematic review. PLoS One. 
2014;9(8):e103754. 
58. Govindasamy D, Kranzer K, van Schaik N, Noubary F, Wood R, Walensky RP, et al. Linkage to 
HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. 
PloS one. 2013;8(11). 
59. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, et al. Leveraging rapid community-
based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 
2012;7(8):e43400. 
60. van Olmen J, Schellevis F, Van Damme W, Kegels G, Rasschaert F. Management of Chronic 
Diseases in Sub-Saharan Africa: Cross-Fertilisation between HIV/AIDS and Diabetes Care. Journal of  
Tropical Medecine. 2012;2012:349312. 
34 
 
61. Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a 
collision course: relevance for health care delivery, particularly in low-resource settings--insights from 
South Africa. The American journal of clinical nutrition 2011;94(6):1690s-6s. 
62. Lekoubou A, Awah P, Fezeu L, Sobngwi E, Kengne AP. Hypertension, Diabetes Mellitus and Task 
Shifting in Their Management in Sub-Saharan Africa. International journal of environmental research 
and public health. 72010. p. 353-63. 
63. Bajis S, Dore GJ, Hajarizadeh B, Cunningham EB, Maher L, Grebely J. Interventions to enhance 
testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject 
drugs: A systematic review. International Journal of Drug Policy. 2017;47:34-46. 
64. Govindasamy D, Kranzer K, van Schaik N, Noubary F, Wood R, Walensky RP, et al. Linkage to 
HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. 
PLoS One. 2013;8(11):e80017. 
65. Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, et al. The burden of hypertension, 
diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences 
for integrated services. BMC Public Health. 2016;16(1):1243. 
66. Maher D, Smeeth L, Sekajugo J. Health transition in Africa: practical policy proposals for primary 
care. Bulletin of the World Health Organization 2010;88(12):943-8. 
67. Duffy M, Ojikutu B, Andrian S, Sohng E, Minior T, Hirschhorn LR. Non‐communicable diseases 
and HIV care and treatment: models of integrated service delivery. Tropical Medicine & International 
Health. 2017;22(8):926-37. 
68. Garrib A, Birungi J, Lesikari S, Namakoola I, Njim T, Cuevas L, et al. Integrated care for human 
immunodeficiency virus, diabetes and hypertension in Africa. Transactions of the Royal Society of 
Tropical Medicine and Hygiene. 2019 Dec 1;113(12):809-12. 
69. Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies NA, et al. Integrating care for 
non‐communicable diseases into routine HIV services: key considerations for policy design in sub‐
Saharan Africa. Journal of the International AIDS Society. 2020;23:e25508. 
70. Adeyemi O, Lyons M, Njim T, Okebe J, Birungi J, Nana K, et al. Integration of non-communicable 
disease and HIV/AIDS management: a review of healthcare policies and plans in East Africa. BMJ 
Global Health. 2021;6(5):e004669. 
71. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed 





Appendix 1: Table 2. Descriptive characteristics of final included studies (Setting, 
Design, Population) 
Author, Year Name of Study Setting Study Design Target Population and 
Diseases 
Anand et al., 
2019[30]  





























Chang et al., 
2019[31] 
Multimorbidity 
and care for 
hypertension, 
diabetes and HIV 
among older 








enrolled in the Health 





























(n=330) on ART who 
attend the HIV clinic 






































disease clinics in 
Uganda in the 
SEARCH study 
Rural Uganda Cluster RCT Residents (n=34,704) of 








multilevel care for 
cardiovascular 
diseases (CVD) 




















integrated into a 





































initiating care at the 
University of Uyo 
Teaching Hospital HIV 
clinic 
 
















People (n=570) who 
received integrated HIV-
NCD testing, counselling 










































(n=20) on NCDs and 




disease, type 2 diabetes, 
cervical cancer, 
depression 




















Current policies and 






Njuguna et al, 
2018[19] 
Models of 
integration of HIV 
and 
noncommunicable 






review of the 
literature 












































(n=141); 57 included in 
qualitative analysis 
 
HIV, CVD, cervical 
cancer, depression, 
diabetes 






and treatment in a 
human 
immunodeficiency 










Rawat et al., 
2018[45] 
Integrated HIV-
care into primary 
care clinics and 
the influence on 
diabetes and 
hypertension care: 
an interrupted time 
series analysis in 
Free State, South 







Data from primary 
health care clinics 
(n=131) with a 









Approach to HIV 
and Hypertension 












Patients (n=443) from 









Mosha et al., 
2017[47] 





Adults (n=9,678) in 
Magu District in 2013 
 
HIV, hypertension, 
diabetes, and other 
chronic diseases 
Pfaff et al., 
2017[48] 
You can treat my 
HIV – But can you 

















Health centres (n=25) 
and hospitals (n=5); 





















(n=270) on Combined 
Antiretroviral Treatment 




Divala et al, 
2016 




risk factors among 
adult Malawians 





Patients (n=952) at the 





Fairall et al., 
2016[50] 
Educational 







Primary Care in 










Patients (n=4,393) of 
public sector primary 



















sampled from 3 
AMPATH clinics: 
Individuals living with 














HIV, tuberculosis (TB), 
hypertension 
Some et al., 
2016[52] 




Diseases to Nurses 
in Kibera, Kenya: 
Does It Work? 




by nurses with patients 
(n=616) in 2 integrated 




epilepsy, asthma, sickle 
cell disease 


















Patients (n=2206)  >14 
years with hypertension 
and/or diabetes 
registered in the  chronic 
diseases clinic from Jan 






















PubMed and general 
search engines and 
websites of WHO, 




cancers, diabetes, COPD 


































model in South 
Africa: lessons in 
the management 
of change through 





quality of clinical 
practice 
Joshi et al., 
2014[57] 





Low and Middle 
Income Countries 





















et al, 2013[58] 
Linkage to HIV, 
TB and Non-
Communicable 
Disease Care from 
a Mobile Testing 








screened at mobile 
testing unit 
 
HIV, TB, diabetes, 
hypertension, 















Residents (n=6300) of 
the rural Ugandan parish   
 





















Patients (n=100 in 
Swaziland and n=260 in 
Ethiopia) with DM 
whose charts were 
randomly reviewed 
 
HIV, diabetes mellitus 












Patients with DM and 
HIV/AIDS 
 
Diabetes mellitus type 2 
and HIV/AIDS. 





































Maher et al., 
2010[63] 
Health transition in 
Africa: practical 
policy proposals 
for primary care 
SSA Narrative 
review 








*PLHIV – People living with HIV 
*LMIC – Low-and-middle income countries 
 
